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Abstract
Background: The forefoot is a preferential location for joint and tendon sheath inflammation in rheumatoid
arthritis (RA). It also contains bursae, of which the intermetatarsal bursae have a synovial lining. Some small imaging
studies suggested that intermetatarsal bursitis (IMB) and submetatarsal bursitis (SMB) are involved in RA, but their
association has not been thoroughly explored. Healthy control studies suggested that lesion size might be relevant.
We studied the relation between IMB and SMB in early RA, compared to other arthritides and healthy controls, and
the relevance of lesion sizes.
Methods: Six hundred and thirty-four participants were studied: 157 consecutive patients presenting with early RA,
284 other arthritides, and 193 healthy controls. All underwent unilateral contrast-enhanced MRI of the forefoot at
presentation. Two readers independently scored IMB and SMB and measured transverse and dorsoplantar
diameters, blinded to clinical data. Subsequently, consensus was reached. Intra-reader ICC was 0.89. Logistic
regression models were used, and test characteristics were calculated.
Results: IMB and SMB associated with RA independent of each other (P < 0.001) and independent of age, gender,
BMI, RA-MRI inflammation, and anti-CCP-antibodies (P = 0.041). Sensitivity for RA of IMB was 69%, and for SMB 25%.
Specificity for IMB was 70% compared to other arthritides, and 84% compared to healthy controls. For SMB, this
was 94% and 97% respectively. Regarding lesion size, the groups had considerable overlap: no cut-off size for RA
could be distinguished with high sensitivity and specificity.
Conclusion: Intermetatarsal and submetatarsal bursitis associated with early rheumatoid arthritis, contributing to
the emerging evidence that inflammation of juxta-articular soft tissues is an early feature of RA.
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Key messages
 Intermetatarsal bursitis and submetatarsal bursitis
associated with RA, and intermetatarsal bursitis had
the highest sensitivity (69%).
 This contributes to the emerging evidence that in
early RA extra-articular synovial inflammation is
common.
 Regarding lesion size no cut-off for disease with high
sensitivity and specificity could be distinguished.
Background
Rheumatoid arthritis (RA) is a systemic autoimmune dis-
ease characterized by chronic, persistent inflammation of
the synovium-lined joints and tendon sheaths [1, 2].
Preferential locations are the small joints of hands and
feet. It has become apparent that early treatment with
disease modifying anti-rheumatic drugs (DMARDs) im-
proves disease outcome of RA patients [3]. Since prompt
treatment has limited radiographic detectable damage,
the European League Against Rheumatism (EULAR) rec-
ommends MRI for the early detection and follow-up of
RA as it sensitively measures inflammation. According
to the RA-MRI score (RAMRIS), inflammation is defined
as synovitis, tenosynovitis, and bone marrow edema/os-
teitis [4, 5]. In the forefoot, however, imaging also re-
veals the presence and/or inflammation of bursae. So
far, bursitis in the forefeet has gained little attention in
RA literature.
Interestingly, naturally present bursae possess a syn-
ovial lining similar to synovial joints and tendon sheaths
[6]. In the forefoot, intermetatarsal bursae are present,
anatomically without a connection to the metatarsopha-
langeal (MTP) joints [7]. Two ultrasound studies have
reported intermetatarsal bursitis (IMB) in patients with
established RA [8, 9]. Additionally, one MRI study in 70
asymptomatic volunteers reported on fluid in the inter-
metatarsal spaces as a sign of IMB [10]. Gadolinium
contrast enhancement was not used as a measure of in-
flammation. The authors suggested that a transverse
diameter of ≤ 3 mm could be considered physiologic;
however, these results have not been validated [10].
Thus, while data suggest that IMB may be associated
with RA, its involvement in early disease has not been
studied systematically.
In the subcutaneous fat, submetatarsal bursae that lack
a synovial lining may develop due to high pressure and
friction, leading to collagen degradation and localized
fluid-collection that is visible on imaging as a sharply de-
marcated area in the submetatarsal space [11]. An ultra-
sound study reported submetatarsal bursitis (SMB) in
patients with established RA [12]. However, this has also
been observed in healthy controls. To the best of our
knowledge, regarding IMB and SMB, no direct
comparison has been made between RA and other arthrit-
ides, which is a comparison that is clinically relevant [13].
Also, no comparison has been made between RA and
healthy controls, to analyze whether these findings could
be normal.
Additionally, in the forefoot, Morton’s neuroma (MN)
and diffuse submetatarsal alterations (DSMA) in the
subcutis have been described. MN may emerge due to
mechanical irritation, or secondary to IMB, and has been
described in RA as well as asymptomatic volunteers
[14–16]. DSMA consist of fibrosis or inflammatory tis-
sue that may be induced by mechanical stress and may
represent early stages in the development of SMB, par-
ticularly under the first and fifth metatarsal heads [17].
Overall, the current available literature does not give a
fulfilling and thorough picture of the prevalence of IMB
and SMB in RA patients. Therefore, this large cross-
sectional MRI study was set up to study (1) the associ-
ation of these lesions in RA, compared to other arthriti-
des and to healthy controls, and (2) whether the size of
these lesions can differentiate between diseases and
healthy controls. Although not the main focus of this
study, MN and DSMA were studied in subanalyses.
Materials and methods
Participants
Between June 2013 and March 2016, 447 consecutive
patients newly presenting with clinical arthritis of a
symptom duration < 2 years who were naïve to DMAR
Ds were included in the Leiden Early Arthritis Cohort
(EAC) [18]. The Leiden University Medical Center is the
only rheumatology referral center within the Leiden
area. Inclusion in the EAC of consecutive early arthritis
patients has been part of regular care since 1993 [19].
Contrast-enhanced MRI of the forefoot was added to the
protocol in June 2013. At baseline, swollen joint counts
were performed, serum samples were obtained, and pa-
tients underwent MRI. Six MRI-examinations were ex-
cluded because of inhomogeneous fat suppression, 441
examinations remained (flowchart in Supplementary Fig-
ure S1). RA was defined as a clinical diagnosis of RA
plus fulfillment of the 2010 RA criteria during the first
year of follow-up [1]. The remaining patients received
alternative diagnoses and were grouped together as
‘other arthritides’ (Table 1).
Healthy controls were recruited by advertisements in
local newspapers and websites, as reported previously
[20]. Participants had no history of inflammatory rheum-
atic disease, no joint symptoms during the last month,
and no arthritis at physical examination.
The EAC and healthy control study were approved by
the local medical ethics committee (approval numbers
P10.108 and P17.261). Informed consent was obtained.
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MRI scanning
Patients and symptom-free persons were scanned ac-
cording to our routine MRI protocol as described in
Supplementary Data S1. They underwent unilateral
MRI of the hand and forefoot of the more painful
side, or the dominant side in case of symmetrical
symptoms, ≤ 2 weeks after the first presentation and
before start of DMARDs. In symptom-free persons,
the dominant side was scanned. A musculoskeletal
extremity 1.5-T MRI unit (Oni; GE Healthcare, Madi-
son, WI, USA) was used with a 145-mm coil. Ac-
quired sequences for the forefoot after intravenous
injection of gadolinium contrast included: axial T1-
weighted fast spin-echo with fat suppression (repeti-
tion time ms/echo time ms 700/9.5; acquisition
matrix 364 × 224, echo train length 2) and coronal
T1-weighted fast spin-echo with fat suppression (540/
7.5; acquisition matrix 320 × 192, echo train length 2).
Field-of-view was 140 mm, slice thickness 3 mm, and
slice gap 0.3 mm for both planes. Axial sequences had
14 slices, and coronal sequences 20 slices.
MRI evaluation
Anatomy and scoring system
The forefoot was divided into four intermetatarsal and
five submetatarsal spaces (Fig. 1) [21]. The intermetatar-
sal space is dorsally bound by the deep dorsal aponeur-
osis and plantar by the superficial transverse metatarsal
ligament [6, 7]. It is divided into a superior and inferior
level by the deep transverse metatarsal ligament. The
intermetatarsal bursae lie in the superior intermetatarsal
spaces [6], the neurovascular bundle, from which MN
originates, lies in the inferior intermetatarsal space and
has a close cohesion with the synovial lining of the inter-
metatarsal bursae [6, 7]. The submetatarsal spaces lie in
the subcutis, plantar to the superficial transverse meta-
tarsal ligament, and extend until the epidermis. We used
the following definitions:
– Intermetatarsal bursitis (IMB). Contrast
enhancement in the superior intermetatarsal space
with or without rim enhancement
– Submetatarsal bursitis (SMB). A sharply demarcated
area with contrast enhancement in the
submetatarsal space with or without rim
enhancement
– Morton’s neuroma (MN). An isolated spindle-
shaped lesion in the inferior intermetatarsal space
with or without contrast enhancement, without rim
enhancement continuous with IMB [10]
– Diffuse submetatarsal alterations (DSMA). An
unsharply defined area in the submetatarsal space
with diffuse contrast enhancement
Lesions had to be visible on two consecutive slices in
both axial and coronal planes. Besides scoring for
Table 1 Baseline characteristics of all participants
RA Other
arthritides1
P value,
RA vs other arthritides
Healthy controls P value,
RA vs healthy controls
n = 157 n = 284 n = 193
Clinical features
Age, mean (SD) 59 (14) 56 (17) 0.07 50 (16) < 0.001
Female, n (%) 109 (69) 158 (56) 0.005 136 (71) 0.83
BMI, mean (SD) 26 (5) 27 (4) 0.52 25 (4) 0.003
Symptom duration, in weeks, median (IQR) 10 (5–28) 8 (4–26) 0.13 NA NA
Swollen joint count, median (IQR) 7 (2–11) 2 (1–4) < 0.001 NA NA
CRP, mg/L, median (IQR) 9 (4–26) 6 (3–16) < 0.001 NA NA
RF positive, n (%) 106 (68) 51 (18) < 0.001 NA NA
ACPA positive, n (%) 87 (59) 69 (25) < 0.001 NA NA
MRI features
Mean number of lesions per patient, n (SD)
Intermetatarsal bursitis 1.6 (1.4) 0.6 (1.0) < 0.001 0.2 (0.7) < 0.001
Submetatarsal bursitis 0.4 (0.8) 0.07 (0.3) < 0.001 0.04 (0.2) < 0.001
Morton’s neuroma 0.4 (0.6) 0.06 (0.3) < 0.001 0.03 (0.2) < 0.001
Diffuse submetatarsal alterations 0.5 (1.1) 0.3 (0.9) 0.068 0.3 (0.9) 0.092
RA rheumatoid arthritis, SD standard deviation, BMI body mass index, IQR interquartile range, CRP C-reactive protein, RF rheumatoid factor, ACPA anti-citrullinated
peptide antigen (anti-CCP), MRI magnetic resonance imaging, NA not applicable
1This group included the following diagnoses: unclassified arthritis (n = 148), psoriatic arthritis or spondyloarthritis (n = 45), inflammatory osteoarthritis (n = 23),
reactive arthritis (n = 7), crystal arthropathy (n = 21), remitting seronegative symmetrical synovitis with pitting edema (n = 12), and other diagnoses (n = 28)
Dakkak et al. Arthritis Research & Therapy          (2020) 22:277 Page 3 of 10
presence, the transverse and dorsoplantar diameter of
IMB, SMB, and MN were measured in millimeters on
coronal images. DSMA was not measured as, per defin-
ition, it has no sharply demarcated borders.
Scoring
Two raters (a musculoskeletal radiologist with 23
years of experience, and a trained MD with 2 years of
experience in RAMRIS scoring and has scored > 400
MRIs according to this system during a training
period of several months prior to evaluating the MRIs
that are part of this study) [22, 23], who were blinded
to all clinical data, independently scored the MRIs.
The two raters determined the final scores by consen-
sus: a lesion was only regarded to be present if both
readers agreed on this. First, all early arthritis patients
were scored, followed by healthy controls. To exclude
observer bias introduced by knowing that images
belonged to healthy controls, MRIs of healthy con-
trols were randomly mixed with 20 MRIs from EAC
patients. Based upon these 20 patients that were
scored twice an intra-reader intraclass correlation co-
efficients (ICC) was determined that was 0.89.
In addition, to explore whether intermetatarsal and
submetatarsal lesions were associated with RA independ-
ent of RAMRIS inflammation, the MRIs were also
scored for synovitis, tenosynovitis, and osteitis at MTP
joints in line with the RAMRIS by two independent
readers, also blinded to clinical data, as is described in
Supplementary Data S1 [22–25]. RAMRIS inflammation
was considered present when synovitis, tenosynovitis,
and/or osteitis were scored as ≥ 1 by both readers.
Analyses
IMB and SMB were studied in RA patients, other ar-
thritides, and healthy controls. First, as patients could
have more than one lesion, e.g., one patient could have
IMB at more than one location, the mean number of le-
sions in RA patients was compared to patients with
other arthritides, and to healthy controls using Mann-
Whitney U tests.
Next, the data was dichotomized for presence per le-
sion: e.g., whether a patient had IMB at any location. Lo-
gistic regression analysis was used to compare RA to
other arthritides and to healthy controls. Multivariable
models corrected for the simultaneous occurrence of the
different lesions and for age, gender, BMI, presence of
RAMRIS inflammation, and anti-citrullinated peptide
antibodies (anti-CCP), as these may be important in the
relation between these lesions and RA [26, 27]. Test
characteristics for RA were determined. Heatmaps were
plotted with the percentage of participants with a lesion
per location. Finally, measured transverse and dorso-
plantar diameters were plotted to assess whether a cut-
off for disease could be observed.
As subanalyses the analyses were repeated for MN and
DSMA.
Calculations were performed with SPSS Statistics, ver-
sion 23.0; IBM, Armonk, NY. P < 0.05 was considered
statistically significant.
Fig. 1 Schematic illustration of the forefoot at the metatarsal heads with intermetatarsal and submetatarsal spaces. The intermetatarsal space is
demarcated at the dorsal side by the deep dorsal aponeurosis (1) and at the plantar side by the superficial transverse metatarsal ligament (2). The
deep transverse metatarsal ligament (3) divides the intermetatarsal space into a superior (4) and inferior part (5), respectively, containing the bursa
and neurovascular bundle (6). The submetatarsal spaces (ST) are located in the subcutis and are artificially bordered by the midline of the
intermetatarsal space (*). M, metatarsal heads. Gray ovals represent extensor and flexor tendons of the forefoot
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Results
Patient characteristics
Of the 441 consecutively included EAC patients, 157
were classified as early RA, 284 patients had other ar-
thritides (Table 1). One hundred and ninety-three
healthy controls were recruited. RA patients were pre-
dominantly female (69%) and had a median symptom
duration of 10 weeks (interquartile range: 5–28).
RA patients had a higher number of IMB and SMB le-
sions per patient compared to other arthritides and to
healthy controls (all P < 0.001) (Table 1). Next, the pres-
ence of a lesion was dichotomized as described in the
Methods.
Association of inter- and submetatarsal bursitis with RA
The number of participants with lesions is given in
Table 2. RA patients more often had IMB and SMB than
other arthritides (all P < 0.001).
Since IMB and SMB were both associated with RA,
and in addition age, gender, BMI, RAMRIS inflamma-
tion, and anti-CCP-antibodies may be important in the
relation between the lesions and RA, a multivariable
model was performed that included both lesions and
these clinical parameters [26, 27]. IMB and SMB
remained associated with RA independent of these fac-
tors (Table 2); the effect size was largest for IMB (OR
4.5, 95%CI 2.7–7.8).
The analyses were repeated comparing RA patients to
healthy controls, revealing similar results (Supplemen-
tary Table S1).
Test characteristics of intermetatarsal and submetatarsal
bursitis for RA
Next, test characteristics were determined for IMB and
SMB (Supplementary Table S2). Sensitivity for IMB was
69%, and for SMB 25%. Specificity of IMB compared to
other arthritides was 70%, and compared to healthy con-
trols 84%. For SMB, this was 94% and 97%, respectively.
Heatmap of lesions for RA, other arthritides, and healthy
controls
The distribution of the lesions was plotted in heatmaps
(Fig. 2, Supplementary Table S3). In RA, IMB affected
the 3rd intermetatarsal space most (57% of patients).
Regarding SMB, the first and fifth submetatarsal space
were most affected: in 13% and 12% of patients,
respectively.
Similarly, in other arthritides and healthy participants,
the 3rd intermetatarsal space was affected by IMB most
often, but with lower frequency (20% and 11% respect-
ively). For SMB at the first and fifth submetatarsal space
this was 2% and 4%, respectively, in other arthritides and
1% and 2% in healthy controls. MRI-examples are given
in Fig. 3.
Transverse and dorsoplantar diameter of lesions for
patients with rheumatoid arthritis, other arthritides, and
healthy controls
Next, the transverse and dorsoplantar diameters of IMB
and SMB were measured (in mm) and plotted in histo-
grams (Fig. 4). We evaluated cut-offs based upon the
histograms (Supplementary Table S4).
First the transverse diameter of IMB was studied.
From the histograms it was apparent that lesions ≥ 4
mm were infrequent in other arthritides (3% of patients)
and healthy controls (2%). We studied whether this
could be used as a cut-off for RA: however lesions ≥ 4
mm were also less frequent in RA (13%). In all groups
the majority of lesions were ≤ 3 mm: 68% of RA patients
had a lesion ≤ 3 mm, compared to 29% other arthritides
and 15% of healthy controls. Hence, a cut-off of 3 mm
increased specificity to 97% compared to other arthriti-
des and 98% to healthy controls, at the cost of a decrease
in sensitivity to 13%.
Theoretically, IMB may be limited by the metatarsal
heads in its ability to distend transversely and may,
therefore, upon inflammation, distend dorsoplantar. A
dorsoplantar diameter of IMB ≥ 15mm was infrequent
in the control groups (Fig. 4). Taking ≥ 15mm as a cut-
Table 2 The association of intermetatarsal and submetatarsal lesions with early RA compared to other early arthritides
Participants with MRI features, n (%) Univariable analyses Multivariable
analysis1
Multivariable
analyses2
RA Other arthritides OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Intermetatarsal bursitis 109 (69) 84 (30) 5.4 (3.5–8.3) < 0.001 4.5 (2.7–7.8) < 0.001 3.7 (2.1–6.6) < 0.001
Submetatarsal bursitis 39 (25) 17 (6) 5.2 (2.8–9.5) < 0.001 2.2 (1.03–4.5) 0.041 2.3 (1.1–4.8) 0.031
Morton’s neuroma 30 (19) 10 (4) 6.7 (3.2–14.2) < 0.001 – – 3.1 (1.3–7.7) 0.012
Diffuse submetatarsal alterations 36 (23) 45 (16) 1.6 (0.9–2.6) 0.067 – – 0.9 (0.5–1.8) 0.86
The results of logistic regression analyses are presented. RA rheumatoid arthritis, OR odds ratio, CI confidence interval
1Multivariable model including intermetatarsal bursitis, submetatarsal bursitis, age, gender, anti-CCP, and RAMRIS inflammation (defined as the presence of
synovitis, tenosynovitis, and/or osteitis)
2Multivariable model including intermetatarsal bursitis, submetatarsal bursitis, Morton’s neuroma, diffuse submetatarsal alterations, age, gender, BMI, anti-CCP
antibodies, and RAMRIS inflammation
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off increased specificity for RA compared to other ar-
thritides (95%) and healthy controls (100%). Sensitivity,
however, decreased to 16%.
Similarly, regarding SMB no cut-off could be deter-
mined that did not lead to a substantial decrease in sen-
sitivity for RA (Supplementary Table S4).
Subanalyses for MN and DSMA
MN was associated with RA compared to other arthriti-
des in univariable and multivariable analyses that in-
cluded IMB, SMB, MN, DSMA and clinical parameters
(P < 0.001 and P = 0.012 respectively). DSMA was not
associated (P = 0.069 and P = 0.86, respectively) (Table
2). Similar results were obtained when compared to
healthy controls (Supplementary Table S1).
The test characteristics for MN were determined and
were as follows: sensitivity 19%, and specificity 96% com-
pared to other arthritides and 98% compared to healthy
controls. For DSMA this was not determined as it was
not associated with RA.
MN and DSMA were incorporated in the heatmaps in
Fig. 2 (Supplementary Table S3 presents the exact fre-
quency per location). MN occurred most frequently in
the third intermetatarsal space (20% of RA patients).
Fig. 2 Heatmap of intermetatarsal bursitis, submetatarsal bursitis, Morton’s neuroma, and diffuse submetatarsal alterations for every population.
Schematic illustration in coronal view of the frequency of lesions in each compartment of the forefoot at the level of the metatarsal heads (see
also supplementary Table S3). The frequency of the lesions (% of participants in the respective group) is represented by an increase in color
intensity. The compartments are defined in Fig. 1. Mortons neuroma (MN) is demarcated plantar to intermetatarsal bursitis (IMB). In the subcutis,
submetatarsal bursitis (SMB) is illustrated as a demarcated oval. The remainder of the subcutis represents diffuse submetatarsal alterations (DSMA).
IMB, SMB, and MN are most frequently seen in RA. The second and third IMB are preferred locations whereas the fourth is the least involved. In
the subcutis of RA patients, DSMA is seen under MTP 2, 3, and 4, whereas in healthy controls, this is seen under MTP 1 and 5. SMB dominates
under MTP 1 and 5 in RA patients. M, metatarsal heads
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Fig. 3 MR examples of intermetatarsal and submetatarsal bursae. Coronal and axial fat suppressed T1-weighted FSE gadolinium-enhanced images
of the forefoot at the level of the metatarsal heads. a Female participant with RA (age 61 years) with intermetatarsal (IMB) and submetatarsal
bursitis (SMB). IMB in the 3rd intermetatarsal space (arrowhead) with peripheral enhancement protruding dorsal (dumbbell shape) and plantar
(teardrop shape) of the metatarsal heads. Peripheral enhancement of a mass in the first submetatarsal space, consistent with SMB (white arrow).
Synovitis of MTP 3 (dotted arrow), as well as osteitis in the head of the third metacarpal bone and proximal phalanx (*). b Female participant with
another arthritide (diagnosis of viral reactive arthritis, age 34 years) and IMB at the 3rd intermetatarsal space (arrowhead) with dorsal protrusion.
Additional synovitis of MTP 1 and 4 (dotted arrows). c Female healthy control (age 50 years) with diffuse submetatarsal alterations (DSMA) in all
submetatarsal spaces, predominantly visible at the 1st, 2nd, and 4th submetatarsal spaces (arrows). Intense linear contrast enhancement at the
2nd intermetatarsal space is consistent with a small vessel on the consecutive slices (not shown), there is no IMB visible on the axial images
Fig. 4 Distribution of transverse and dorsoplantar diameters (mm) of intermetatarsal bursitis, submetatarsal bursitis, and Morton’s neuroma. The x-
axis displays the diameter (in mm), the y-axis the percentage of participants with the corresponding diameter. Participants could have more than
one lesion; therefore, the percentage of participants with a lesion does not add up to the total amount of participants. The metatarsal bones limit
the IMB in the transverse plane, squeezing the bursa outwards in the dorsoplantar plane. The SMB expands more in the transverse than
dorsoplantar plane in the subcutis. The detected MN are predominantly round and larger than 5 mm
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DSMA in the first and fifth submetatarsal space were
relatively more common in healthy controls (both loca-
tions 10%).
Regarding lesion size for MN, a transverse diameter of
≥ 7 mm was infrequent in control groups (Fig. 4): using
this cut-off increased specificity for RA, however sensi-
tivity decreased to 12%. Additionally, literature suggests
a cut-off of ≥ 5 mm, this decreased sensitivity to 16%
[10, 28]. Similarly, for the dorsoplantar diameter, using a
≥ 4 mm cut-off based on Fig. 4 decreased sensitivity to
13% (Supplementary Table S4). DSMA was not mea-
sured as, per definition, it has no sharply demarcated
borders.
Discussion
This cross-sectional study aimed to explore MRI-
detected IMB and SMB in consecutive patients present-
ing with early RA, compared to other arthritides and
healthy controls. We observed that both IMB and SMB
were associated with and specific for RA (specificity ran-
ging from 70 to 97%). In addition, we studied whether
lesion size might be relevant and found considerable
overlap in size between the groups; therefore, no cut-off
for RA could be distinguished with high sensitivity and
specificity. To our knowledge, our study is the largest to
date to systematically study involvement of bursae in the
forefoot in RA.
IMB results from inflammation of a naturally present,
synovium-lined, structure [6]. Since RA is a disease of
the synovium, the bursae might be a primary focus of
disease, previously unnoticed. It can be hypothesized
that IMB occurs secondary to concomitant arthritis;
however, there is no anatomical connection between
intermetatarsal bursae and MTP joints and in our study
IMB associated with RA independent of the presence of
RAMRIS inflammation, defined as synovitis, tenosyno-
vitis, and osteitis [7].
In the plantar subcutaneous fat of the forefoot SMB was
scored as sharply demarcated submetatarsal areas of con-
trast enhancement with or without rim enhancement that
may develop secondary to mechanical loading [17]. These
non-native (adventitious) bursae form at sites of friction
but have imaging features similar to native bursae [29].
In addition MN and DSMA were scored, of which MN
was also associated with RA. This association remained
present after correcting for age, gender, and BMI; fea-
tures that may relate to other pathologies predisposing
to MN. Thus, MN seems to be increased in RA. Within
RA, IMB has previously been suggested as a cause of
MN [14, 30]. Inflamed bursae may irritate the common
plantar digital nerve [6, 30], with secondary MN forma-
tion [7, 30]. This may explain why MN mostly occurred
at locations where IMB was most frequent (second and
third intermetatarsal spaces). For the definition of MN,
besides the shape and location, it was important in our
study that the lesion did not have any rim enhancement
that was continuous with the IMB. This might be espe-
cially challenging at the second and third intermetatarsal
spaces, where enlarged intermetatarsal bursae can ex-
tend below the deep transverse metatarsal ligament to-
wards the neurovascular bundle [10]. In the literature
the prevalence for MN varies between studies, from 15%
in symptomatic volunteers to 54% in asymptomatic vol-
unteers [10, 16, 31]. An explanation for the low fre-
quency of 20% in our study could be the challenging
differentiation between MN and IMB and potential co-
existence of the two, especially for smaller MN. The lim-
ited MRI protocol, without T1 and fluid-sensitive se-
quences, may underscore fibrous MN [32]. Therefore,
no definitive conclusion regarding the frequency of MN
can be drawn from our study. We do not believe this
undermines the association that was found of MN with
RA, as the protocol restriction applies for all study
groups.
DSMA, interestingly, occurred in healthy controls spe-
cifically under the first and fifth metatarsal heads. These
locations are consistent with a previous study and are
considered a normal finding based on mechanical load-
ing [17]. In RA, DSMA occurred predominantly under
MTP 2, 3, and 4, whereas under MTP 1 and 5 SMB were
seen (Fig. 2).
It is difficult to compare our findings to previous stud-
ies in RA, as they utilized ultrasound and included pa-
tients with established RA receiving treatment rather
than early disease [8, 33].
The intermetatarsal space is limited in the transverse
plane by the metatarsal bones. Thus, bursitis is squeezed
either dorsal and or plantar, especially at the second and
third intermetatarsal spaces, respectively called a dumbbell
or a teardrop phenomenon (Fig. 1), explaining the larger
dorsoplantar diameter that is found (Fig. 4) [7, 21].
Our study has some limitations. First, the scoring
method is not validated; therefore, reading was done by
consensus rather than by independent readers, as this
may be necessary in the setting of preliminary findings
[34]. However, for determining the validity of an out-
come measure, it is crucial to demonstrate the reliability
of scoring between independent readers [34, 35]. The
Intra-reader ICC, however, was determined and was re-
assuring. Second, our MRI protocol contained no fluid-
sensitive sequences, as the protocol was originally
intended to score RAMRIS inflammation. Therefore,
small amounts of fluid in the bursae may have remained
undetected, leading to an underestimation of observed
lesions. Nevertheless, the use of contrast enhancement
might be a strength, which previous studies in early
arthritis found essential for optimal assessment of MRI-
detected synovitis and tenosynovitis [25, 36]. Because
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intermetatarsal bursae have a synovial lining, we as-
sumed that contrast enhancement would increase sensi-
tivity of synovial hypertrophy in (active) bursitis. Thus,
although theoretically small amounts of fluid in a bursa
may be missed without a fluid-sensitive sequence, this
could be normal in a bursa and rarely occurs at this lo-
cation without enhancing synovial hypertrophy [10, 37].
The greater prevalence of contrast-enhancing (teno-
)synovitis might be expected to occur in RA. To account
for this we included RAMRIS inflammation in our mul-
tivariable model. Third, although the lesions were associ-
ated with RA independent of the factors that were
adjusted for, additional factors might be of influence to
the occurrence of these lesions, such as physical activity
and type of shoes that were unaccounted for and may
potentially be a source of bias. Also, we did not include
a comparison with weight-bearing radiographs [38, 39].
Finally, our study was cross-sectional in nature. Thus, al-
though our study suggests that these lesions may aid the
clinician as a (differential) diagnostic tool, prospective
studies are warranted to further establish the diagnostic
relevance of these lesions.
Conclusion
IMB and SMB are both associated with RA. As IMB has
a synovial lining, these results contribute to the emer-
ging evidence that in early RA, besides intra-articular
synovitis, juxta-articular synovial inflammation is com-
mon. Previously, tenosynovitis was reported [18, 36],
and now IMB as well. The current findings pose ques-
tions on whether the bursitis correlated to symptoms,
responds to therapy, or has diagnostic value, e.g., in pre-
dicting RA development in the early phases of disease.
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